PNC Financial Services Group Inc. lowered its holdings in Cooper Companies Inc (NYSE:COO) by 0.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 38,393 shares of the medical device company’s stock after selling 94 shares during the period. PNC Financial Services Group Inc.’s holdings in Cooper Companies were worth $10,584,000 at the end of the most recent quarter.
Other large investors have also recently modified their holdings of the company. Savior LLC purchased a new position in Cooper Companies during the fourth quarter valued at approximately $30,000. Evolution Wealth Advisors LLC grew its stake in Cooper Companies by 1,125.0% in the 4th quarter. Evolution Wealth Advisors LLC now owns 98 shares of the medical device company’s stock worth $31,000 after buying an additional 90 shares in the last quarter. Harvest Fund Management Co. Ltd purchased a new position in Cooper Companies in the 1st quarter worth approximately $34,000. Total Clarity Wealth Management Inc. purchased a new position in Cooper Companies in the 4th quarter worth approximately $64,000. Finally, CSat Investment Advisory L.P. grew its stake in Cooper Companies by 18.5% in the 4th quarter. CSat Investment Advisory L.P. now owns 211 shares of the medical device company’s stock worth $68,000 after buying an additional 33 shares in the last quarter. 88.92% of the stock is owned by institutional investors.
Shares of Cooper Companies stock opened at $287.80 on Friday. Cooper Companies Inc has a 52-week low of $236.68 and a 52-week high of $365.68. The stock has a market capitalization of $15.35 billion, a price-to-earnings ratio of 31.66, a price-to-earnings-growth ratio of 2.19 and a beta of 0.90. The company has a fifty day moving average of $294.82 and a 200-day moving average of $313.43. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.58 and a current ratio of 1.08.
Cooper Companies (NYSE:COO) last announced its quarterly earnings data on Thursday, March 5th. The medical device company reported $2.69 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $2.71 by ($0.02). Cooper Companies had a net margin of 16.99% and a return on equity of 16.74%. The business had revenue of $646.20 million during the quarter, compared to analysts’ expectations of $648.04 million. During the same period last year, the company posted $2.88 EPS. Cooper Companies’s revenue for the quarter was up 2.9% on a year-over-year basis. On average, equities research analysts forecast that Cooper Companies Inc will post 11.96 earnings per share for the current fiscal year.
A number of equities analysts have commented on the stock. Piper Sandler boosted their price target on shares of Cooper Companies from $344.00 to $351.00 in a research note on Friday, March 6th. Stephens cut their price target on shares of Cooper Companies from $375.00 to $300.00 and set an “overweight” rating for the company in a research note on Monday, March 23rd. Stifel Nicolaus boosted their price target on shares of Cooper Companies from $320.00 to $350.00 and gave the stock a “buy” rating in a research note on Friday, March 6th. Jefferies Financial Group cut their price target on shares of Cooper Companies from $360.00 to $340.00 and set a “buy” rating for the company in a research note on Wednesday, April 8th. Finally, Robert W. Baird boosted their price target on shares of Cooper Companies from $345.00 to $357.00 and gave the stock an “outperform” rating in a research note on Friday, March 6th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Cooper Companies currently has an average rating of “Buy” and a consensus target price of $339.50.
Cooper Companies Company Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.